U.S. flag An official website of the United States government
  1. Home
  2. Safety
  3. Recalls, Market Withdrawals, & Safety Alerts
  4. Regeneca Worldwide, a Division of Vivaceuticals, Inc., Issues a Nationwide Recall of Its Products
  1. Safety

COMPANY ANNOUNCEMENT

Regeneca Worldwide, a Division of Vivaceuticals, Inc., Issues a Nationwide Recall of Its Products

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Read Announcement

Regeneca Worldwide, a Division of Vivaceuticals, Inc., Issues a Nationwide Recall of Its Products

Summary

Company Announcement Date:
March 09, 2017
FDA Publish Date:
February 07, 2018
Product Type:
Food & Beverages
Food & Beverage Safety
Reason for Announcement:
Company Name:
Regeneca Worldwide
Brand Name:
Brand Name(s)
Regeneca Worldwide
Product Description:
Product Description
Various herbal and dietary supplements

Company Announcement

Regeneca Worldwide, a division of VivaCeuticals, Inc. is conducting a nationwide recall of its entire line of herbal and dietary supplement products pursuant to a Consent Decree entered by the federal court for the Central District of California. This recall applies to all products manufactured and sold between June 1, 2011 and February 8, 2017. These products include, but are not limited to RegeneSlim, RegenErect, RegeneArouse, RegeneBlend, RegeneBoost, RegeneBlast, and RegeneFit. ALL LOT #s ARE INCLUDED IN THIS RECALL. Regeneca products were sold nationwide online using the company's websites, and through a direct sales force within the United States and Puerto Rico for both consumption and retail sales.

The company has presently ceased doing business in the United States.

Consumers who have purchased Regeneca products subject to this recall are advised to immediately stop using the product and are urged to return it to the place of purchase for a possible exchange. Consumers with questions may contact the
company via email to support@regeneca.com.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Consumers

Regeneca Support
support@regeneca.com